Niklas Broman - UTU Research Portal

Niklas Broman

- Doctoral Researcher,
Internal Medicine (Department of Clinical Medicine)

nsbrom@utu.fi

Guidelines to practice in hospitals at home : safe and effective continuous infusion pumps substantially increased penicillin use in erysipelas treatmentAssociation of human myxovirus resistance protein A with severity of COVID-19 (2024)
- European Journal of Public HealthBMC Infectious Diseases
Metsä-Simola, Niina; Saarenketo, Jenni; Lehtonen, Henri; Broman, Niklas; Häggblom, Tony; Björklöf, Pia; Sariola, Salla; Valta, Maija P
Antibioottipumput vähentävät sairaalahoitojaEarly administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM—a prospective, randomized, single-centre, open-label study (2023)
- Lääkärilehti
Lehtola Laura, Broman Niklas, Järvinen Asko
Rapid implementation of home oxygen treatment and remote monitoring for COVID-19 patients at the verge of the Omicron wave in Turku, Finland (2023)
- BMC Infectious DiseasesClinical Microbiology and Infection
Hänninen Janne, Anttalainen Ulla, Kilpeläinen Maritta, Hohenthal Ulla, Broman Niklas, Palmen Jenni, Oksi Jarmo, Feuth Thijs
2022
Lehtinen Otto, Broman Niklas, Waris Matti, Vuorinen Tytti, Peltola Ville, Löyttyniemi Eiisa, Oksi Jarmo, Feuth Thijs
2022
- Clinical Microbiology and Infection
Broman Niklas, Feuth Matthijs, Vuorinen Tytti, Valtonen Mika, Hohenthal Ulla, Löyttyniemi Eliisa, Hirvioja Tiina, Jalava-Karvinen Päivi, Marttila Harri, Nordberg Marika, Oksi Jarmo
‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’ – Author's reply (2022)
Broman Niklas, Feuth Thijs, Oksi Jarmo; COVIDSTORM study group
Association between Administration of IL-6 Antagonists and Mortality among Patients Hospitalized for COVID-19: A Meta-analysis (2021)
- JAMA: Journal of the American Medical Association
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group
IL-6 and other biomarkers as predictors of severity in COVID-19 (2021)
- Annals of Medicine
Broman N, Rantasärkkä K, Feuth T, Valtonen M, Waris M, Hohenthal U, Rintala E, Karlsson A, Marttila H, Peltola V, Vuorinen T, Oksi J